R&D channel feed

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

4 weeks ago

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

4 weeks ago
Pharma

Keytru­da around head and neck can­cer surgery cuts chance of dis­ease com­ing back

4 weeks ago

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

4 weeks ago

J&J re­ports dura­bil­i­ty da­ta for blad­der can­cer 'pret­zel' drug af­ter FDA fil­ing

4 weeks ago

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

4 weeks ago
Pharma
FDA+

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

4 weeks ago
China

Hop­ing to turn CD47 around with Keytru­da com­bo, ALX On­col­o­gy re­ports two Phase 2 fail­ures

4 weeks ago

Cari­bou lays off 32% of staff, cuts lu­pus cell ther­a­py pro­gram be­fore first pa­tient

4 weeks ago
People
Cell/Gene Tx

Sanofi's Al­tuvi­i­io clos­ing in on block­buster sta­tus, Dupix­ent sales surge

4 weeks ago
Pharma

As­cle­tis posts puz­zling Phase 1 up­date on obe­si­ty pill

4 weeks ago

Ake­so re­ports an­oth­er Phase 3 win for PD-1xVEGF ap­proach in lung can­cer

4 weeks ago

Boehringer taps Dutch biotech for ALT pos­i­tive can­cer pact ex­ceed­ing $573M in biobucks

4 weeks ago
Deals

Bris­tol My­er­s' schiz­o­phre­nia drug fails Phase 3 tri­al for ad­junc­tive treat­ment

4 weeks ago
Pharma

As­traZeneca, Dai­ichi eye first-line breast can­cer mar­ket af­ter En­her­tu's ear­ly Phase 3 win

4 weeks ago
Pharma

Chi­na start­up in­jects CRISPR ther­a­py in­to the brain for the first time

5 weeks ago
Startups
China

Trodelvy and Keytru­da com­bo suc­ceeds in Phase 3 breast can­cer study

5 weeks ago

Roivant brings rare dis­ease pro­gram clos­er as Im­muno­vant CEO re­tires

5 weeks ago
People

Roche dis­con­tin­ues low dose in Hunt­ing­ton’s tri­al, will switch pa­tients to high dose

Last month

Nether­lands pours $1.5B in­to biotech in pur­suit of glob­al lead­er­ship am­bi­tions

Last month
Financing

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

Last month

CDC ad­vi­sors broad­en RSV vac­cine rec­om­men­da­tions to at-risk adults in their 50s

Last month

Gly­comine rais­es $115M to see if it can treat rare gly­co­sy­la­tion dis­or­der

Last month
Financing
Startups

Mur­al On­col­o­gy ends clin­i­cal de­vel­op­ment, lays off most work­ers

Last month
People
First page Previous page 123456 Next page Last page
A service from the Financial Times